Inmune Bio, Inc. (INMB)
INmune Bio, Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies. Its primary objective is to harness the body's innate immune system to combat various illnesses. The company is actively engaged in developing and bringing to market therapeutic candidates designed to address a spectrum of conditions such as blood cancers, solid tumors, and chronic inflammatory diseases. Its pipeline features key development programs including: INKmune: Aimed at treating women suffering from relapsed or refractory ovarian carcinoma and individuals diagnosed with high-risk myelodysplastic syndrome. INB03: An immunotherapy targeting patients with both hematologic malignancies and solid tumors. XPro1595: Under development for the treatment of Alzheimer's disease. INmune Bio holds licensing agreements with entities including Xencor, Inc., Immune Ventures, LLC, the University of Pittsburgh, and University College London. Established in 2015, INmune Bio is headquartered in Boca Raton, Florida.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
INmune Bio, Inc.
NASDAQ:INMBHealthcare · Biotechnology
-9.38%$1.45
AH$1.43-1.38%vs close
Mkt Cap$40.24M
Float24.75M
O/S27.75M
Vol
$ Vol
RVOL
Inst Own15.6%
SI11.7%
Earnings
Dilution
Financials Summary
Revenue$50K
Net Income-$45.93M
Total Assets$32.35M
Free Cash Flow-$23.62M
Debt & Equity
Debt 4%
Equity 96%
Total Debt$1.03M
Total Equity$23.52M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in INMB's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$32.35M
Liabilities$8.83M
Accounts Receivable$4.54M
Accounts Payable$7.77M
Inventory$0
PP&E (Net)$914K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Revenue | $50K | $14K | $155K | $374K | $181K | $11K | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | 257.1% | -91.0% | -58.6% | 106.6% | 1545.5% | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $50K | $14K | $155K | $374K | $181K | $11K | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | - | - | - | - | - |
| Research and Development | $20.66M | $33.17M | $20.27M | $17.07M | $20.54M | $5.92M | $3.28M | $1.1M | $435K | $101K | $0 |
| Selling, General, and Administrative | $10.26M | $9.48M | $9.62M | $9.26M | $8.79M | $6.32M | $4.47M | $9.09M | $546K | $126K | $49K |
| Other | $0 | $0 | $0 | $0 | $0 | $1K | $0 | $0 | -$6 | $0 | $0 |
| Total Operating Expenses | $30.92M | $42.65M | $29.9M | $26.32M | $29.33M | $12.24M | $7.76M | $12.44M | $981K | $227K | $49K |
| Operating Income (EBIT) | -$30.87M | -$42.63M | -$29.74M | -$25.95M | -$29.15M | -$12.23M | -$7.76M | -$12.44M | -$981K | -$227K | -$49K |
| Operating Margin | -61738.0% | -304535.7% | -19187.7% | -6938.8% | -16106.6% | -111163.6% | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $850K | $0 | $0 | $0 | $0 | $0 | $78K | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$15.06M | $553K | -$267K | -$1.35M | -$1.19M | $129K | $78K | $0 | $150K | -$50K | $0 |
| Income Before Tax (EBT) | -$45.93M | -$42.08M | -$30.01M | -$27.3M | -$30.34M | -$12.1M | -$7.68M | -$12.44M | -$831K | -$277K | -$49K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$45.93M | -$42.08M | -$30.01M | -$27.3M | -$30.34M | -$12.1M | -$7.68M | -$12.44M | -$831K | -$277K | -$49K |
| Net Income Margin | -91866.0% | -300585.7% | -19360.0% | -7299.2% | -16762.4% | -109990.9% | - | - | - | - | - |
| Supplementary Data | |||||||||||
| EPS | -1.86 | -2.11 | -1.67 | -1.52 | -1.88 | -1.01 | -0.89 | -1.11 | -0.07 | -0.05 | -0.01 |
| Diluted EPS | -1.86 | -2.11 | -1.67 | -1.52 | -1.88 | -1.01 | -0.89 | -1.11 | -0.07 | -0.05 | -0.01 |
| Weighted Average OS | 26.59M | 19.94M | 17.98M | 17.93M | 16.13M | 11.99M | 10.27M | 11.22M | 11.22M | 5.11M | 5.00M |
| EBITDA | -$45.85M | -$41.53M | -$267K | -$1.35M | -$1.19M | $0 | -$7.68M | $23 | $150K | -$50K | $147K |
| EBITDA Margin | -91698.0% | -296635.7% | -172.3% | -360.4% | -655.8% | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $24.75M | $20.92M | $35.85M | $52.15M | $74.81M | $21.97M | $7M | $186K | $1.37M | $142K | $12K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $24.75M | $20.92M | $35.85M | $52.15M | $74.81M | $21.97M | $7M | $186K | $1.37M | $142K | $12K |
| Accounts Receivable | $4.54M | $1.41M | $2.44M | $8.46M | $5.5M | $0 | $645K | $648K | $328K | $0 | $0 |
| Inventory | $0 | $0 | $0 | $34K | -$5.5M | $0 | -$769.13M | $0 | $0 | $0 | $0 |
| Other Current Assets | $595K | $331K | $1.51M | -$34K | $5.5M | $1.8M | $769.13M | $0 | $0 | $307K | $0 |
| Total Current Assets | $29.89M | $22.66M | $39.94M | $64.67M | $82.61M | $23.99M | $7.76M | $849K | $1.9M | $452K | $12K |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $914K | $307K | $414K | $507K | $726K | $156K | $192K | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $16.51M | $16.51M | $16.51M | $16.51M | $16.51M | $16.51M | $16.51M | $16.51M | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $1.55M | $79K | $131K | $99K | $99K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $2.46M | $16.9M | $17.06M | $17.12M | $17.34M | $16.67M | $16.71M | $16.51M | $16.51M | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $32.35M | $39.56M | $57M | $81.8M | $99.94M | $40.66M | $24.47M | $17.36M | $18.41M | $452K | $12K |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $7.77M | $6.56M | $7.9M | $5.21M | $3.8M | $1.52M | $402K | $553K | $136K | $221K | $750 |
| Short-Term Debt | $0 | $0 | $9.92M | $5M | $0 | $0 | $0 | $0 | $0 | $350K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $616K | $474K | $0 | -$298K | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $517K | $524K | $9K | $10K | $190K | $298K | $0 | $0 | $30K | $30K |
| Total Current Liabilities | $8.42M | $7.22M | $18.46M | $10.92M | $4.36M | $1.78M | $700K | $824K | $310K | $601K | $31K |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $0 | $0 | $0 | $9.7M | $14.46M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $550K | $199K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $411K | $244K | $397K | $10.77M | $15.36M | $126K | $160K | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $8.83M | $7.46M | $18.86M | $21.69M | $19.72M | $1.9M | $861K | $824K | $310K | $601K | $31K |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $27K | $22K | $817K | $18K | $18K | $13K | $11K | $9K | $8K | $5K | $5K |
| Retained Earnings | -$209.04M | -$163.1M | -$121.02M | -$91.01M | -$63.72M | -$33.38M | -$21.28M | -$13.6M | -$1.16M | -$326K | -$49K |
| Comprehensive Income & Other | -$737K | -$575K | -$799K | -$699K | $1K | $11K | -$9K | $7K | $32K | $47K | $0 |
| Other Stockholders' Equity | $232.53M | $195.18M | $158.34M | $151.1M | $143.92M | $72.12M | $44.88M | $30.13M | $19.25M | $172K | $25K |
| Total Equity | $23.52M | $32.1M | $38.14M | $60.1M | $80.22M | $38.75M | $23.61M | $16.54M | $18.1M | -$149K | -$19K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $32.35M | $39.56M | $57M | $81.8M | $99.94M | $40.66M | $24.47M | $17.36M | $18.41M | $452K | $12K |
| Supplementary Data | |||||||||||
| Total Debt | $1.03M | $384K | $10.44M | $15.31M | $15.23M | $160K | $168K | $0 | $0 | $350K | $0 |
| Net Debt | -$23.72M | -$20.54M | -$25.41M | -$36.84M | -$59.58M | -$21.81M | -$6.83M | -$186K | -$1.37M | $208K | -$12K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
| Operating Activities | |||||||||||
| Net Income | -$45.93M | -$42.08M | -$30.01M | -$27.3M | -$30.34M | -$12.1M | -$7.68M | -$12.44M | -$831K | -$277K | -$49K |
| Depreciation & Amortization | $84K | $0 | $29.74M | $25.95M | $29.15M | $12.23M | $0 | $12.44M | $981K | $227K | $195K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $9.91M | $7.61M | $7.37M | $7.15M | $4.8M | $0 | $4.1M | $10M | $200K | $0 | $120K |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | -$3.13M | $1.03M | $6.02M | -$2.96M | -$3.71M | -$1.15M | $2K | -$320K | -$67K | -$260K | $0 |
| Inventory | $0 | $0 | $0 | $2.96M | $3.71M | $0 | -$2K | $0 | $0 | $0 | $0 |
| Accounts Payable | $1.85M | -$1.37M | $2.72M | $1.4M | $2.26M | $1.08M | -$132K | $514K | $239K | $220K | $0 |
| Other Working Capital | -$1.25M | $1.38M | $1.7M | -$4.27M | -$5.35M | $121K | -$129K | -$134K | -$219K | -$310K | $750 |
| Total Working Capital Change | -$2.53M | $1.04M | $10.44M | -$2.86M | -$3.09M | $44K | -$261K | $380K | $20K | -$90K | $750 |
| Other Non-Cash Items | $15.89M | $79K | -$29.52M | -$25.62M | -$29.03M | -$9.12M | -$1.54M | -$12.44M | -$1.13M | -$177K | -$285K |
| Net Cash from Operating | -$22.58M | -$33.36M | -$11.98M | -$22.69M | -$28.5M | -$8.94M | -$5.38M | -$2.06M | -$762K | -$317K | -$18K |
| Investing Activities | |||||||||||
| Capital Expenditures | -$1.04M | $0 | $0 | $0 | -$15M | $0 | $0 | $0 | -$100K | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$100K | $0 | $0 |
| Net Cash from Investing | -$1.04M | $0 | $0 | $0 | -$15M | $0 | $0 | $0 | -$100K | $0 | $0 |
| Financing Activities | |||||||||||
| Debt Repaid | - | $10M | $5M | - | -$14.95M | - | - | - | - | - | - |
| Common Stock Issuance | $27.61M | $27.79M | $775K | $699K | $80.25M | $24.91M | $12.21M | $900K | $2.06M | $100K | $30K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | -$1.01M | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $422K | $0 | $30K | $1.15M | $0 | $0 | $0 | $0 | $0 | $120K |
| Net Cash from Financing | $27.61M | $18.21M | -$4.22M | $729K | $96.36M | $23.9M | $12.21M | $900K | $2.06M | $450K | $30K |
| Forex Effect | -$159K | $224K | -$100K | -$700K | -$10K | $19K | -$15K | -$26K | $35K | -$3K | $0 |
| Net Change in Cash | $3.83M | -$14.93M | -$16.3M | -$22.66M | $52.84M | $14.97M | $6.81M | -$1.18M | $1.23M | $130K | $12K |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$22.58M | -$33.36M | -$11.98M | -$22.69M | -$28.5M | -$8.94M | -$5.38M | -$2.06M | -$762K | -$317K | -$18K |
| Capital Expenditure | -$1.04M | $0 | $0 | $0 | -$15M | -$4 | $0 | $0 | -$100K | $0 | $0 |
| Free Cash Flow | -$23.62M | -$33.36M | -$11.98M | -$22.69M | -$43.5M | -$8.94M | -$5.38M | -$2.06M | -$862K | -$317K | -$18K |
| Cash at Beginning | $20.92M | $35.85M | $52.15M | $74.81M | $21.97M | $7M | $186K | $1.37M | $142K | $12K | $0 |
| Cash at End | $24.75M | $20.92M | $35.85M | $52.15M | $74.81M | $21.97M | $7M | $186K | $1.37M | $142K | $12K |